rs1342387

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_015999.6(ADIPOR1):c.431-59A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.543 (AC=769,944) in the gnomAD database across 1,418,200 control chromosomes, including 210,210 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.602. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 21299 hom., cov: 32)
Exomes 𝑓: 0.54 ( 188911 hom. )

Consequence

ADIPOR1
NM_015999.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.66

Publications

71 publications found
Variant links:
Genes affected
ADIPOR1 (HGNC:24040): (adiponectin receptor 1) This gene encodes a protein which acts as a receptor for adiponectin, a hormone secreted by adipocytes which regulates fatty acid catabolism and glucose levels. Binding of adiponectin to the encoded protein results in activation of an AMP-activated kinase signaling pathway which affects levels of fatty acid oxidation and insulin sensitivity. A pseudogene of this gene is located on chromosome 14. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2014]
ADIPOR1 Gene-Disease associations (from GenCC):
  • retinitis pigmentosa
    Inheritance: SD, AD Classification: MODERATE, LIMITED Submitted by: PanelApp Australia, Franklin by Genoox

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_015999.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6022 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_015999.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADIPOR1
NM_015999.6
MANE Select
c.431-59A>G
intron
N/ANP_057083.2
ADIPOR1
NM_001290553.2
c.431-59A>G
intron
N/ANP_001277482.1Q96A54
ADIPOR1
NM_001290557.1
c.431-59A>G
intron
N/ANP_001277486.1Q96A54

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADIPOR1
ENST00000340990.10
TSL:1 MANE Select
c.431-59A>G
intron
N/AENSP00000341785.5Q96A54
ADIPOR1
ENST00000367254.7
TSL:1
c.430+1211A>G
intron
N/AENSP00000356223.3F8W782
ADIPOR1
ENST00000855702.1
c.431-59A>G
intron
N/AENSP00000525761.1Q96A54

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80196
AN:
151976
Hom.:
21263
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.521
Gnomad AMI
AF:
0.312
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.471
Gnomad EAS
AF:
0.620
Gnomad SAS
AF:
0.520
Gnomad FIN
AF:
0.479
Gnomad MID
AF:
0.449
Gnomad NFE
AF:
0.549
Gnomad OTH
AF:
0.528
GnomAD4 exome
AF:
0.545
AC:
689667
AN:
1266106
Hom.:
188911
AF XY:
0.544
AC XY:
337321
AN XY:
620224
show subpopulations
African (AFR)
AF:
0.516
AC:
14589
AN:
28280
American (AMR)
AF:
0.467
AC:
10146
AN:
21732
Ashkenazi Jewish (ASJ)
AF:
0.464
AC:
9136
AN:
19678
East Asian (EAS)
AF:
0.554
AC:
19960
AN:
36060
South Asian (SAS)
AF:
0.495
AC:
29390
AN:
59334
European-Finnish (FIN)
AF:
0.497
AC:
22534
AN:
45368
Middle Eastern (MID)
AF:
0.438
AC:
1526
AN:
3486
European-Non Finnish (NFE)
AF:
0.554
AC:
554546
AN:
1000298
Other (OTH)
AF:
0.537
AC:
27840
AN:
51870
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
14749
29497
44246
58994
73743
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16354
32708
49062
65416
81770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.528
AC:
80277
AN:
152094
Hom.:
21299
Cov.:
32
AF XY:
0.525
AC XY:
39056
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.522
AC:
21633
AN:
41480
American (AMR)
AF:
0.484
AC:
7401
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.471
AC:
1634
AN:
3466
East Asian (EAS)
AF:
0.620
AC:
3207
AN:
5172
South Asian (SAS)
AF:
0.519
AC:
2501
AN:
4822
European-Finnish (FIN)
AF:
0.479
AC:
5062
AN:
10560
Middle Eastern (MID)
AF:
0.449
AC:
131
AN:
292
European-Non Finnish (NFE)
AF:
0.549
AC:
37299
AN:
67992
Other (OTH)
AF:
0.533
AC:
1125
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1966
3932
5899
7865
9831
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
712
1424
2136
2848
3560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
TOPMed (Bravo)
AF:
0.526
AC:
139325
AN:
264690
Hom.:
36882
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF:
0.536
AC:
145530
AN:
271324
Hom.:
39098

Local populations

ABraOM SABE-WGS-1171
AF:
0.529
AC:
1240
AN:
2342
Hom.:
327
ChinaMAP Phase 1
AF:
0.636
Denmark Genome
AF:
0.517
AC:
155
AN:
300
GenomeAsia100K
AF:
0.578
AC:
2008
AN:
3478
show subpopulations
Oceania
AF:
0.905
AC:
134
AN:
148
Hom.:
61
North-East Asia
AF:
0.511
AC:
359
AN:
702
Hom.:
95
South-East Asia
AF:
0.676
AC:
468
AN:
692
Hom.:
159
South Asia
AF:
0.566
AC:
820
AN:
1448
Hom.:
240
Africa
AF:
0.481
AC:
100
AN:
208
Hom.:
26
America
AF:
0.308
AC:
16
AN:
52
Hom.:
3
West Eurasia
AF:
0.487
AC:
111
AN:
228
Hom.:
31
Korea4K (4,157 Koreans)
AF:
0.552
AC:
3995
AN:
7234
Qatari Genome
AF:
0.386
AC:
68
AN:
176
ToMMo 61KJPN (+60KJPN MNV)
AF:
0.514
AC:
63052
AN:
122706
Hom.:
16282
Turkish Variome
AF:
0.462
AC:
715
AN:
1546
Hom.:
160
UK10K
AF:
0.560
AC:
4233
AN:
7562
show subpopulations
TwinsUK
AF:
0.546
AC:
1952
AN:
3574
ALSPAC
AF:
0.573
AC:
2207
AN:
3854
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.646
AC:
5785
AN:
8960
Hom.:
1883

Case/control cohorts

Cohort
Cases
Controls
SCHEMA
(Schizophrenia)
22130 / 54924AF: 0.402920
35817 / 91882AF: 0.389815

Allele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.52
DANN
Benign
0.66
PhyloP100
-1.7
AlphaGenome AVI
Benign
0.87
GPN-Star LLR
2.6
GPN-Star score
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2
Pangolin (max)
Benign
0.0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.